ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
| Brand name | OSENI |
|---|---|
| Active ingredient | ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
| Strength | EQ 12.5MG BASE;EQ 30MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | January 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8637079 | June 2029 | product |
| 7807689 | June 2028 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.